{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:11:35Z","timestamp":1786983095210,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vaccinations are among the most effective interventions against infectious diseases such as measles, influenza, and COVID-19. Nevertheless, there are significant differences in vaccination readiness. The aim of this study was to validate the 7\u00a0C scale, which measures seven psychological factors comprising general vaccination readiness, in both German and Greek, and to investigate differences in vaccination behavior between a German and a Greek sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted with a convenience sample of 576 study participants, of whom 319 responded to the online survey in German and 257 in Greek. Analyses included internal consistency, structural validity, construct validity through the known-groups method, item analysis, and floor and ceiling effects. The two samples differed significantly in terms of demographic data such as age, gender and education, as well as in religiosity and vaccination behavior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The German sample showed a higher vaccination rate for most vaccinations, except for vaccinations against hepatitis A, varicella, and meningococcal disease, wheras in the Greek sample, there were significantly more \u201cI don\u2019t know\u201d responses regarding vaccination status. The 7\u00a0C scale of vaccination readiness demonstrated acceptable to good psychometric properties in terms of both internal consistency and construct validity in both samples, although there were some weaknesses in the component that measures\n                      <jats:italic>calculation<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:sup>\n                      in both the 21-item and 7-item versions. The 7-component structure was confirmed using a confirmatory factor analysis. The German and the Greek samples differ primarily in the components\n                      <jats:italic>confidence<\/jats:italic>\n                      ,\n                      <jats:italic>complacency<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:sup>\n                      , and\n                      <jats:italic>conspiracy<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>R<\/jats:italic>\n                      <\/jats:sup>\n                      , with significantly higher values in the German sample. Binary logistic regression analysis demonstrated that the 7\u00a0C scale had the lowest predictive value for measles vaccination and the highest for COVID-19.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The German and Greek versions of the 7\u00a0C scale are invaluable research tools for investigating vaccination readiness. A comprehensive understanding of the underlying factors contributing to vaccine hesitancy is imperative for the development of culturally tailored educational initiatives. These initiatives must be designed to address prevalent misconceptions regarding vaccination, with the objective of enhancing vaccination rates, and promoting public health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s44197-025-00485-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:27:45Z","timestamp":1763731665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The 7\u00a0C Vaccination Readiness Scale: An Empirical Country Comparison Between Germany and Greece"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-3409","authenticated-orcid":false,"given":"Birgit","family":"Teichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-026X","authenticated-orcid":false,"given":"Ioannis","family":"Ladas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-153X","authenticated-orcid":false,"given":"Demosthenes B.","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"485_CR1","unstructured":"Europ\u00e4ische Kommission. Public Health: Vaccination. 2024. https:\/\/health.ec.europa.eu\/vaccination\/overview_de."},{"key":"485_CR2","unstructured":"WHO, Vaccines. and immunization. 2025. https:\/\/www.who.int\/health-topics\/vaccines-and-immunization\/#tab=tab_1."},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","volume":"47","author":"B Serrano","year":"2018","unstructured":"Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14\u201326. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.006.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ijc.33313","volume":"148","author":"J-F Shi","year":"2021","unstructured":"Shi J-F, Cao M, Wang Y, Bai F-Z, Lei L, Peng J, et al. Is it possible to halve the incidence of liver cancer in China by 2050? Int J Cancer. 2021;148:1051\u201365. https:\/\/doi.org\/10.1002\/ijc.33313.","journal-title":"Int J Cancer"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: building a bridge over troubled waters. Cell. 2022;185:2770\u201388. https:\/\/doi.org\/10.1016\/j.cell.2022.06.035.","journal-title":"Cell"},{"key":"485_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, et al. Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond. Transl Neurodegener. 2022;11:18. https:\/\/doi.org\/10.1186\/s40035-022-00292-3.","journal-title":"Transl Neurodegener"},{"key":"485_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.11526","volume":"39","author":"X Niu","year":"2021","unstructured":"Niu X, Wei F, Tu C, Huang G, Bi W, Li J, et al. Efficacy and safety of JMT103 in patients with giant cell tumor of bone: a multicenter, single-arm, open-label, phase Ib\/II study. JCO. 2021;39:11526. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.11526.","journal-title":"JCO"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-publhealth-090419-102240","volume":"42","author":"\u00c8 Dub\u00e9","year":"2021","unstructured":"Dub\u00e9 \u00c8, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Annu Rev Public Health. 2021;42:175\u201391. https:\/\/doi.org\/10.1146\/annurev-publhealth-090419-102240.","journal-title":"Annu Rev Public Health"},{"key":"485_CR9","unstructured":"WHO. Ten threats to global health in 2019. 2019. https:\/\/www.who.int\/vietnam\/news\/feature-stories\/detail\/ten-threats-to-global-health-in-2019."},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0264-410x(89)90229-6","volume":"7","author":"AH Griffith","year":"1989","unstructured":"Griffith AH. Permanent brain damage and pertussis vaccination: is the end of the saga in sight? Vaccine. 1989;7:199\u2013210. https:\/\/doi.org\/10.1016\/0264-410x(89)90229-6.","journal-title":"Vaccine"},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7326\/M18-2101","volume":"170","author":"A Hviid","year":"2019","unstructured":"Hviid A, Hansen JV, Frisch M, Melbye M, Measles. Mumps, Rubella vaccination and autism: A nationwide cohort study. Ann Intern Med. 2019;170:513\u201320. https:\/\/doi.org\/10.7326\/M18-2101.","journal-title":"Ann Intern Med"},{"issue":"4","key":"485_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10995-019-02856-8","volume":"24","author":"RP Theis","year":"2020","unstructured":"Theis RP, Wells BA, Staras SAS. I can be the judge of what\u2019s serious: a qualitative pilot study of parents\u2019 responses to messaging about side effects of the HPV vaccine. Matern Child Health J. 2020;24(4):456\u201361. https:\/\/doi.org\/10.1007\/s10995-019-02856-8.","journal-title":"Matern Child Health J"},{"key":"485_CR13","unstructured":"WHO. Coronavirus disease (COVID-19) pandemic. 2024. https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19."},{"key":"485_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00180-4","volume":"9","author":"EU Haq","year":"2020","unstructured":"Haq EU, Yu J, Guo J. Frontiers in the COVID-19 vaccines development. Exp Hematol Oncol. 2020;9:24. https:\/\/doi.org\/10.1186\/s40164-020-00180-4.","journal-title":"Exp Hematol Oncol"},{"issue":"Suppl 1","key":"485_CR15","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/s0264-410x(01)00306-1","volume":"20","author":"RE Spier","year":"2001","unstructured":"Spier RE. Perception of risk of vaccine adverse events: a historical perspective. Vaccine. 2001;20(Suppl 1):S78\u201384. https:\/\/doi.org\/10.1016\/s0264-410x(01)00306-1. discussion S75-7.","journal-title":"Vaccine"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/nejmp1010594","volume":"364","author":"GA Poland","year":"2011","unstructured":"Poland GA, Jacobson RM. The age-old struggle against the antivaccinationists. N Engl J Med. 2011;364:97\u20139. https:\/\/doi.org\/10.1056\/nejmp1010594.","journal-title":"N Engl J Med"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1016\/j.vaccine.2013.11.006","volume":"32","author":"S Tafuri","year":"2014","unstructured":"Tafuri S, Gallone MS, Cappelli MG, Martinelli D, Prato R, Germinario C. Addressing the anti-vaccination movement and the role of HCWs. Vaccine. 2014;32:4860\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.006.","journal-title":"Vaccine"},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","volume":"378","author":"HJ Larson","year":"2011","unstructured":"Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. Lancet. 2011;378:526\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(11)60678-8.","journal-title":"Lancet"},{"issue":"S1","key":"485_CR19","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.53730\/ijhs.v8nS1.15436","volume":"8","author":"FTH Alanazi","year":"2024","unstructured":"Alanazi FTH, Alharbi BN, Aljuaid TH, Alammar FA, Almarzouq YF, Albalawi I, et al. The impact of vaccinations on disease prevention: a comprehensive analysis of their role in enhancing global public health and reducing morbidity and mortality rates. Int J Health Sci. 2024;8(S1):1885\u2013907. https:\/\/doi.org\/10.53730\/ijhs.v8nS1.15436.","journal-title":"Int J Health Sci"},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/ehr.13019","volume":"73","author":"L Shaw-Taylor","year":"2020","unstructured":"Shaw-Taylor L. An introduction to the history of infectious diseases, epidemics and the early phases of the long-run decline in mortality. Econ Hist Rev. 2020;73:E1-19. https:\/\/doi.org\/10.1111\/ehr.13019.","journal-title":"Econ Hist Rev"},{"key":"485_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003354","volume":"17","author":"B Baumgaertner","year":"2020","unstructured":"Baumgaertner B, Ridenhour BJ, Justwan F, Carlisle JE, Miller CR. Risk of disease and willingness to vaccinate in the United States: a population-based survey. PLoS Med. 2020;17:e1003354. https:\/\/doi.org\/10.1371\/journal.pmed.1003354.","journal-title":"PLoS Med"},{"key":"485_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033245","volume":"9","author":"EO Oduwole","year":"2019","unstructured":"Oduwole EO, Pienaar ED, Mahomed H, Wiysonge CS. Current tools available for investigating vaccine hesitancy: a scoping review protocol. BMJ Open. 2019;9:e033245. https:\/\/doi.org\/10.1136\/bmjopen-2019-033245.","journal-title":"BMJ Open"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4161\/hv.24657","volume":"9","author":"E Dub\u00e9","year":"2013","unstructured":"Dub\u00e9 E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9:1763\u201373. https:\/\/doi.org\/10.4161\/hv.24657.","journal-title":"Hum Vaccin Immunother"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","volume":"194","author":"G Troiano","year":"2021","unstructured":"Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245\u201351. https:\/\/doi.org\/10.1016\/j.puhe.2021.02.025.","journal-title":"Public Health"},{"key":"485_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-022-00123-6","volume":"2","author":"C Leong","year":"2022","unstructured":"Leong C, Jin L, Kim D, Kim J, Teo YY, Ho T-H. Assessing the impact of novelty and conformity on hesitancy towards COVID-19 vaccines using mRNA technology. Commun Med. 2022;2:61. https:\/\/doi.org\/10.1038\/s43856-022-00123-6.","journal-title":"Commun Med"},{"key":"485_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/473443a","volume":"473","author":"J Leask","year":"2011","unstructured":"Leask J. Target the fence-sitters. Nature. 2011;473:443\u20135. https:\/\/doi.org\/10.1038\/473443a.","journal-title":"Nature"},{"key":"485_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-12-154","volume":"12","author":"J Leask","year":"2012","unstructured":"Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012;12:154. https:\/\/doi.org\/10.1186\/1471-2431-12-154.","journal-title":"BMC Pediatr"},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.036.","journal-title":"Vaccine"},{"key":"485_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/2372732215600716","volume":"2","author":"C Betsch","year":"2015","unstructured":"Betsch C, B\u00f6hm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2:61\u201373. https:\/\/doi.org\/10.1177\/2372732215600716.","journal-title":"Policy Insights Behav Brain Sci"},{"key":"485_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","volume":"73","author":"LA Grohskopf","year":"2024","unstructured":"Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season. MMWR Recomm Rep. 2024;73:1\u201325. https:\/\/doi.org\/10.15585\/mmwr.rr7305a1.","journal-title":"MMWR Recomm Rep"},{"key":"485_CR31","doi-asserted-by":"publisher","first-page":"1437942","DOI":"10.3389\/fpsyg.2024.1437942","volume":"15","author":"AA Schulz","year":"2024","unstructured":"Schulz AA, Abt Y, von Oppen L, Wirtz MA. Readiness for influenza and COVID-19 vaccination in germany: a comparative analysis. Front Psychol. 2024;15:1437942. https:\/\/doi.org\/10.3389\/fpsyg.2024.1437942.","journal-title":"Front Psychol"},{"key":"485_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-658-43429-8_5","volume-title":"Konspiration","author":"A Schink","year":"2024","unstructured":"Schink A. Covid-19: Verschw\u00f6rungstheorien, experten und der Kampf gegen Sie in der Krise. In: Anton A, Schetsche M, Walter MK, editors. Konspiration. Wiesbaden: Springer Fachmedien Wiesbaden; 2024. pp. 89\u2013121. https:\/\/doi.org\/10.1007\/978-3-658-43429-8_5."},{"key":"485_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208601","volume":"13","author":"C Betsch","year":"2018","unstructured":"Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, B\u00f6hm R. Beyond confidence: development of a measure assessing the 5 C psychological antecedents of vaccination. PLoS ONE. 2018;13:e0208601. https:\/\/doi.org\/10.1371\/journal.pone.0208601.","journal-title":"PLoS ONE"},{"key":"485_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1027\/1015-5759\/a000663","volume":"38","author":"M Geiger","year":"2022","unstructured":"Geiger M, Rees F, Lilleholt L, Santana AP, Zettler I, Wilhelm O, et al. Measuring the 7Cs of vaccination readiness. Eur J Psychol Assess. 2022;38:261\u20139. https:\/\/doi.org\/10.1027\/1015-5759\/a000663.","journal-title":"Eur J Psychol Assess"},{"key":"485_CR35","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-25-01730","author":"PJ Hotez","year":"2025","unstructured":"Hotez PJ. Measles. mumps, rubella immunization and the resurgence of measles in America. Ann Intern Med. 2025. https:\/\/doi.org\/10.7326\/ANNALS-25-01730.","journal-title":"Ann Intern Med"},{"key":"485_CR36","unstructured":"RKI, Impfen. COVID-19-ImpfempfehlungStand 4.4. (2025). 2025. https:\/\/www.rki.de\/SharedDocs\/FAQs\/DE\/Impfen\/COVID-19\/FAQ_Liste_STIKO_Empfehlungen.html."},{"key":"485_CR37","unstructured":"Paul-Ehrlich-Institut. Impfstoffe. 2024. https:\/\/www.pei.de\/DE\/arzneimittel\/impfstoffe\/impfstoffe-node.html."},{"key":"485_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040424","author":"A Saha","year":"2025","unstructured":"Saha A, Ghosh Roy S, Dwivedi R, Tripathi P, Kumar K, Nambiar SM, et al. Beyond the pandemic era: recent advances and efficacy of SARS-CoV-2 vaccines against emerging variants of concern. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13040424.","journal-title":"Vaccines"},{"key":"485_CR39","unstructured":"Leiner D. SoSci Survey \u2023 Onlinebefragung, DSGVO-konform, deutsches Unternehmen. 26.04.2025. https:\/\/www.soscisurvey.de\/."},{"key":"485_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"485_CR41","doi-asserted-by":"publisher","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17. https:\/\/doi.org\/10.3352\/jeehp.2021.18.17.","journal-title":"J Educ Eval Health Prof"},{"key":"485_CR42","volume-title":"The consequentialist scale: elucidating the role of deontological and utilitarian beliefs in moral judgments","author":"JS Robinson","year":"2012","unstructured":"Robinson JS. The consequentialist scale: elucidating the role of deontological and utilitarian beliefs in moral judgments. Toronto, Canada: University of Toronto; 2012."},{"key":"485_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1027\/1015-5759.23.3.193","volume":"23","author":"B Rammstedt","year":"2007","unstructured":"Rammstedt B. The 10-item big five inventory. Eur J Psychol Assess. 2007;23:193\u2013201. https:\/\/doi.org\/10.1027\/1015-5759.23.3.193.","journal-title":"Eur J Psychol Assess"},{"key":"485_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1467-6494.2011.00749.x","volume":"80","author":"M Brunner","year":"2012","unstructured":"Brunner M, Nagy G, Wilhelm O. A tutorial on hierarchically structured constructs. J Pers. 2012;80:796\u2013846. https:\/\/doi.org\/10.1111\/j.1467-6494.2011.00749.x.","journal-title":"J Pers"},{"key":"485_CR45","unstructured":"Geiger M, Rees F, Lilleholt L, Santana AP, Zettler I, Wilhelm O et al. Oct. RMeasure & Materials \u2013\u20097\u00a0C - a COSMO webpage. 10.01.2023. https:\/\/vaccination-readiness.com\/materials\/."},{"key":"485_CR46","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.17823.92329","author":"W Lenhard","year":"2022","unstructured":"Lenhard W, Alexandra Lenhard. Computation of effect sizes. Psychometrica. 2022. https:\/\/doi.org\/10.13140\/RG.2.2.17823.92329.","journal-title":"Psychometrica"},{"key":"485_CR47","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. New York: Lawrence Erlbaum Associates; 1988."},{"key":"485_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","volume":"2","author":"M Tavakol","year":"2011","unstructured":"Tavakol M, Dennick R. Making sense of cronbach\u2019s alpha. Int J Med Educ. 2011;2:53\u20135. https:\/\/doi.org\/10.5116\/ijme.4dfb.8dfd.","journal-title":"Int J Med Educ"},{"key":"485_CR49","doi-asserted-by":"crossref","unstructured":"McDonald RP. Test theory. Psychology. 2013.","DOI":"10.1093\/oxfordhb\/9780199934874.013.0007"},{"key":"485_CR50","unstructured":"Wirtz M. McDonald\u2019s Omega (\u03c9) im Dorsch Lexikon der Psychologie. 2024."},{"key":"485_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34\u201342. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.03.012.","journal-title":"J Clin Epidemiol"},{"key":"485_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","volume":"107","author":"PM Bentler","year":"1990","unstructured":"Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238\u201346. https:\/\/doi.org\/10.1037\/0033-2909.107.2.238.","journal-title":"Psychol Bull"},{"key":"485_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1999","unstructured":"Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1\u201355. https:\/\/doi.org\/10.1080\/10705519909540118.","journal-title":"Struct Equ Modeling"},{"key":"485_CR54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1207\/s15327906mbr2502_4","volume":"25","author":"JH Steiger","year":"1990","unstructured":"Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivar Behav Res. 1990;25:173\u201380. https:\/\/doi.org\/10.1207\/s15327906mbr2502_4.","journal-title":"Multivar Behav Res"},{"issue":"12","key":"485_CR55","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1037\/pas0000626","volume":"31","author":"LA Clark","year":"2019","unstructured":"Clark LA, Watson D. Constructing validity: new developments in creating objective measuring instruments. Psychol Assess. 2019;31(12):1412\u201327. https:\/\/doi.org\/10.1037\/pas0000626.","journal-title":"Psychol Assess"},{"key":"485_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06678-9","volume":"21","author":"T Myloneros","year":"2021","unstructured":"Myloneros T, Sakellariou D. The effectiveness of primary health care reforms in Greece towards achieving universal health coverage: a scoping review. BMC Health Serv Res. 2021;21:628. https:\/\/doi.org\/10.1186\/s12913-021-06678-9.","journal-title":"BMC Health Serv Res"},{"key":"485_CR57","unstructured":"Bundesgesetzblatt. Gesetz zur Verh\u00fctung und Bek\u00e4mpfung \u00fcbertragbarer Krankheiten beim Menschen (Bundes-Seuchengesetz). 1961. https:\/\/www.bgbl.de\/xaver\/bgbl\/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl161s1012.pdf#\/text\/bgbl161s1012.pdf?_ts=1744055255493."},{"key":"485_CR58","unstructured":"RKI. Epidemiologisches Bulletin 50\/2024. 2024."},{"key":"485_CR59","unstructured":"BMG. Warum brauchen wir eine gesetzliche Impfpflicht gegen Masern? 2020. https:\/\/www.bundesgesundheitsministerium.de\/impfpflicht\/faq-masernschutzgesetz.html."},{"key":"485_CR60","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","volume":"72","author":"AA Minta","year":"2023","unstructured":"Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al. Progress toward measles elimination \u2014 worldwide, 2000\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72:1262\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"485_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-018-0504-y","volume":"44","author":"E Bozzola","year":"2018","unstructured":"Bozzola E, Spina G, Russo R, Bozzola M, Corsello G, Villani A. Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. Ital J Pediatr. 2018;44:67. https:\/\/doi.org\/10.1186\/s13052-018-0504-y.","journal-title":"Ital J Pediatr"},{"key":"485_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19052879","author":"HC Maltezou","year":"2022","unstructured":"Maltezou HC, Rahiotis C, Tseroni M, Madianos P, Tzoutzas I. Attitudes toward vaccinations and vaccination coverage rates among dental students in Greece. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19052879.","journal-title":"Int J Environ Res Public Health"},{"key":"485_CR63","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1017\/S0950268818002170","volume":"146","author":"T Georgakopoulou","year":"2018","unstructured":"Georgakopoulou T, Horefti E, Vernardaki A, Pogka V, Gkolfinopoulou K, Triantafyllou E, et al. Ongoing measles outbreak in Greece related to the recent European-wide epidemic. Epidemiol Infect. 2018;146:1692\u20138. https:\/\/doi.org\/10.1017\/S0950268818002170.","journal-title":"Epidemiol Infect"},{"key":"485_CR64","unstructured":"WHO. Global measles and rubella strategic plan: 2012\u20132020. 2012."},{"key":"485_CR65","unstructured":"RKI. Epidemiologisches Bulletin 50\/2021. 2021."},{"key":"485_CR66","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00103-013-1693-6","volume":"56","author":"C Poethko-M\u00fcller","year":"2013","unstructured":"Poethko-M\u00fcller C, Schmitz R. Impfstatus von erwachsenen in deutschland: ergebnisse der studie Zur gesundheit erwachsener in Deutschland (DEGS1). [Vaccination coverage in German adults: results of the German health interview and examination survey for adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:845\u201357. https:\/\/doi.org\/10.1007\/s00103-013-1693-6.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"485_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12040378","author":"D Papagiannis","year":"2024","unstructured":"Papagiannis D, Thireos E, Mariolis A, Katsioulis A, Lampropoulos IC, Tsiaousi I, et al. Diphtheria and tetanus immunity status among Greek adults: results from a nationwide seroprevalence study. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12040378.","journal-title":"Vaccines"},{"key":"485_CR68","doi-asserted-by":"publisher","first-page":"282","DOI":"10.22365\/jpsych.2024.019","volume":"35","author":"EE Kantidakis","year":"2024","unstructured":"Kantidakis EE, Symvoulakis EK, Basta M, Chourdaki E, Dimitriou H. Vaccination coverage of persons using hospital outpatient mental health services at Heraklion, Crete, greece: A cross-sectional study during pandemic. Psychiatriki. 2024;35:282\u201392. https:\/\/doi.org\/10.22365\/jpsych.2024.019.","journal-title":"Psychiatriki"},{"key":"485_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126435","volume":"42","author":"S Papailiou","year":"2024","unstructured":"Papailiou S, Soldatou A, Marmarinos A, Avgeris M, Papathoma E, Sindos M, et al. Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece - a cross- sectional study. Vaccine. 2024;42:126435. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126435.","journal-title":"Vaccine"},{"key":"485_CR70","unstructured":"National Hellenic Health Organisation. Epidemiological, data for hepatitis a in. Greece, 2004\u20132023 mandatory notification system. 2024."},{"key":"485_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116939","volume":"10","author":"K Mellou","year":"2015","unstructured":"Mellou K, Sideroglou T, Papaevangelou V, Katsiaflaka A, Bitsolas N, Verykouki E, et al. Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks. PLoS One. 2015;10:e0116939. https:\/\/doi.org\/10.1371\/journal.pone.0116939.","journal-title":"PLoS One"},{"key":"485_CR72","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000382","volume":"148","author":"K Mellou","year":"2020","unstructured":"Mellou K, Chrysostomou A, Sideroglou T, Kyritsi M, Georgakopoulou T, Tsiodras S, et al. Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned. Epidemiol Infect. 2020;148:e58. https:\/\/doi.org\/10.1017\/S0950268820000382.","journal-title":"Epidemiol Infect"},{"key":"485_CR73","first-page":"237","volume":"4","author":"F Babatsikou","year":"2010","unstructured":"Babatsikou F, Vorou R, Vardaki Z, Galani S, Ktenas E. Childhood vaccination uptake and factors affecting this in Athens, Greece. HEALTH Sci J OURNAL. 2010;4:237\u201344.","journal-title":"HEALTH Sci J OURNAL"},{"key":"485_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1574-695x.1999.tb01716.x","volume":"23","author":"J Kremastinou","year":"1999","unstructured":"Kremastinou J, Tzanakaki G, Kansouzidou A, Pagalis A, Danielides V, Kouppari G, et al. Recent emergence of serogroup C meningococcal disease in Greece. FEMS Immunol Med Microbiol. 1999;23:49\u201355. https:\/\/doi.org\/10.1111\/j.1574-695x.1999.tb01716.x.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"485_CR75","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1469-0691.2007.01704.x","volume":"13","author":"DA Kafetzis","year":"2007","unstructured":"Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, Konstantopoulos A, et al. Meningococcal group C disease in Greece during 1993\u20132006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clin Microbiol Infect. 2007;13:550\u20132. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01704.x.","journal-title":"Clin Microbiol Infect"},{"key":"485_CR76","doi-asserted-by":"publisher","first-page":"107275","DOI":"10.1016\/j.ijid.2024.107275","volume":"149","author":"WA Fleischmann","year":"2024","unstructured":"Fleischmann WA, Le Cao C, Nurjadi D, Velavan TP. Addressing the rise of autochthonous vector-borne diseases in a warming Europe. Int J Infect Dis. 2024;149:107275. https:\/\/doi.org\/10.1016\/j.ijid.2024.107275.","journal-title":"Int J Infect Dis"},{"key":"485_CR77","unstructured":"RKI. FSME-Risikogebiete in Deutschland. 2025. https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Infektionskrankheiten-A-Z\/F\/FSME\/Karte_FSME.pdf?__blob=publicationFile&v=4."},{"key":"485_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taae153","author":"N Beerlage-de Jong","year":"2025","unstructured":"Beerlage-de Jong N, Blanford J. Mapping the risk of tick-borne encephalitis in Europe for informed vaccination decisions. J Travel Med. 2025. https:\/\/doi.org\/10.1093\/jtm\/taae153.","journal-title":"J Travel Med"},{"key":"485_CR79","unstructured":"t-online. FSME-F\u00e4lle deutlich gestiegen: Impfquoten laut RKI noch sehr gering. t-online. 11.11.2024."},{"key":"485_CR80","unstructured":"RKI, St\u00e4ndige. Impfkommission: Impfkalender 2025. 2025."},{"key":"485_CR81","unstructured":"\u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u03b4\u03b7\u00b5\u03bf\u03ba\u03c1\u03b1\u03c4\u03af\u03b1 \u03a5\u03c0\u03bf\u03c5\u03c1\u03b3\u03b5\u03af\u03bf \u03a5\u03b3\u03b5\u03af\u03b1\u03c2. \u039f\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u0395\u03c0\u03bf\u03c7\u03b9\u03ba\u03ae \u0393\u03c1\u03af\u03c0\u03b7 2024\u20132025: \u0391\u03bd\u03c4\u03b9\u03b3\u03c1\u03b9\u03c0\u03b9\u03ba\u03cc\u03c2 \u0395\u00b5\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u00b5\u03cc\u03c2. 2024."},{"key":"485_CR82","unstructured":"Corona-in-Zahlen.de. Corona-Impfungen und Impfquoten in Deutschland. 2024. https:\/\/www.corona-in-zahlen.de\/impfungen\/."},{"key":"485_CR83","unstructured":"data.gov.gr. \u03a3\u03c4\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ac \u03b5\u00b5\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u00b5\u03bf\u03cd \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd COVID-19. 2024. https:\/\/data.gov.gr\/datasets\/mdg_emvolio\/."},{"key":"485_CR84","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1016\/j.vaccine.2022.04.091","volume":"40","author":"F Rees","year":"2022","unstructured":"Rees F, Geiger M, Lilleholt L, Zettler I, Betsch C, B\u00f6hm R, et al. Measuring parents\u2019 readiness to vaccinate themselves and their children against COVID-19. Vaccine. 2022;40:3825\u201334. https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.091.","journal-title":"Vaccine"},{"key":"485_CR85","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ajic.2022.07.001","volume":"51","author":"M Machida","year":"2023","unstructured":"Machida M, Kojima T, Popiel HA, Geiger M, Odagiri Y, Inoue S. Development, validity, and reliability of the Japanese version of the 7 C of vaccination readiness scale. Am J Infect Control. 2023;51:426\u201333. https:\/\/doi.org\/10.1016\/j.ajic.2022.07.001.","journal-title":"Am J Infect Control"},{"key":"485_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7883\/yoken.jjid.2023.261","volume":"77","author":"M Machida","year":"2024","unstructured":"Machida M, Inoue S, Tabuchi T. General vaccination readiness in Japan: results from the JASTIS 2023 study. Jpn J Infect Dis. 2024;77:34\u20139. https:\/\/doi.org\/10.7883\/yoken.jjid.2023.261.","journal-title":"Jpn J Infect Dis"},{"key":"485_CR87","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/08964289.2022.2071198","volume":"49","author":"M Kyprianidou","year":"2023","unstructured":"Kyprianidou M, Konstantinou P, Alvarez-Galvez J, Ceccarelli L, Gruszczy\u0144ska E, Mierzejewska-Floreani D, et al. Profiling hesitancy to COVID-19 vaccinations in six European countries: behavioral, attitudinal and demographic determinants. Behav Med. 2023;49:362\u201373. https:\/\/doi.org\/10.1080\/08964289.2022.2071198.","journal-title":"Behav Med"},{"key":"485_CR88","unstructured":"Cohen S. Herd immunity: What is it and what happens if we don\u2019t reach it for COVID-19? 2021. https:\/\/www.uclahealth.org\/news\/article\/understanding-covid-19-herd-immunity-what-is-it-and-what-happens-if-we-dont-reach-it. Accessed 18 May 2025."},{"key":"485_CR89","first-page":"492","volume":"119","author":"B Halbe","year":"2022","unstructured":"Halbe B. Einrichtungsbezogene impfpflicht: die Pflicht zum Nachweis der Immunit\u00e4t gegen COVID-19. Dtsch Arztebl Int. 2022;119:492.","journal-title":"Dtsch Arztebl Int"},{"key":"485_CR90","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1016\/j.vaccine.2021.07.056","volume":"39","author":"PF Burke","year":"2021","unstructured":"Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions. Vaccine. 2021;39:5116\u201328. https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.056.","journal-title":"Vaccine"},{"key":"485_CR91","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00787-021-01878-4","volume":"32","author":"E Humer","year":"2023","unstructured":"Humer E, Jesser A, Plener PL, Probst T, Pieh C. Education level and COVID-19 vaccination willingness in adolescents. Eur Child Adolesc Psychiatry. 2023;32:537\u20139. https:\/\/doi.org\/10.1007\/s00787-021-01878-4.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"485_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-021-01677-w","author":"S Zintel","year":"2022","unstructured":"Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis. J Public Health. 2022. https:\/\/doi.org\/10.1007\/s10389-021-01677-w.","journal-title":"J Public Health"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-025-00485-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:27:57Z","timestamp":1763731677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-025-00485-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1007\/s44197-025-00485-9","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the Faculty of Behavioral and Empirical Cultural Sciences of Heidelberg University (AZ Teich 2024 3\/1). All procedures involved in this work conformed to the ethical standards of the Declaration of Helsinki as applied to national and institutional human experimentation committees. Written informed consent was obtained from each participant before the start of the survey. Participants were informed that the study was voluntary, confidential, anonymous, and for scientific purposes only.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}